We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Innovaderma Plc | LSE:IDP | London | Ordinary Share | GB00BT9PTW34 | ORD EUR0.10 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
TIDMIDP
RNS Number : 0989X
InnovaDerma PLC
29 April 2021
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA (SUBJECT TO CERTAIN LIMITED EXCEPTIONS), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE OF THIS ANNOUNCEMENT.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ("UK MAR").
29 April 2021
InnovaDerma PLC
("InnovaDerma" or the "Company")
Result of Open Offer and General Meeting
and
Director/PDMR Shareholding
InnovaDerma (LSE: IDP), a leading UK developer and supplier of beauty, personal care and life sciences products, is pleased to announce that, further to the announcement on 12 April 2021, the Resolutions put to Shareholders at the General Meeting held earlier today in connection with the 9,981,040 new ordinary shares pursuant to the Placing and Open Offer (together the "Fundraising") were duly passed. Voting was held by way of a poll and all of the votes cast by way of the poll were cast in favour of the resolutions.
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meaning as defined in the announcement the Placing, and Open Offer made by the Company on 20 January 2021.
Result of Open Offer
In addition, the Company is pleased to announce that valid applications have been received in respect of, and the Company will issue, 1,449,469 Open Offer Shares, raising gross proceeds of GBP0.5 million and taking the total proceeds of the Fundraising to GBP4.5 million.
The Company received valid acceptances in excess of the 1,449,469 Open Offer Shares being offered to Qualifying Shareholders. The Open Offer was significantly oversubscribed and the Directors will use their discretion to undertake an appropriate scaling back process.
Director/PDMR Shareholding
The Company has been notified that Ross Andrews, Non-Executive Chairman of the Company has taken up entitlements to subscribe for 13,145 additional new Ordinary Shares under the Open Offer.
As a result of this transaction, Ross Andrews' beneficial interest in the Company following Admission is 322,290 Ordinary Shares representing 1.17 per cent of the Company's total voting rights.
Admission & Total Voting Rights
Application has been made to the London Stock Exchange for the 9,981,040 New Ordinary Shares to be admitted to trading. It is expected that Admission will become effective and dealings will commence in the Second Admission Shares at 8.00 a.m. on 30 April 2021.
Following Admission, the Company will have in issue 27,374,673 Ordinary Shares, with no shares held in treasury. Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.
Blake Hughes, CEO of InnovaDerma said:
"I would like to thank our current and new shareholders for their commitment and strong vote of confidence in InnovaDerma. Whilst we have made good progress over recent months, including enhancing our digital marketing expertise and rolling out a new Skinny Tan website, this investment opens up an exciting future for transforming InnovaDerma. It will enable us to further accelerate the execution of our sharpened Company strategy, shared in March, through capital investment in our e-commerce and operational capabilities, as well as strengthening the balance sheet.
"Through this new digital and consumer insight centric strategy, and supported by our UK based, digitally focused board, we now have the right agility, the right structure and the right resources in place to succeed in the digital e-commerce driven world which we live in today.
"This is an exciting time for New InnovaDerma and I look forward to updating shareholders with our future progress."
Further enquiries
Hot Features
Premium
InnovaDerma
Blake Hughes c/o TB Cardew
finnCap Group
Geoff Nash/Kate Bannatyne/Edward Whiley +44 (0)207 220 0500
Alice Lane/Charlotte Sutcliffe - ECM www.finncap.com
----------------------------
TB Cardew
Shan Shan Willenbrock/ + 44 (0)7775 848537
Olivia Rosser + 44 (0)20 7930 0777
innovaDerma@tbcardew.com
----------------------------
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Pursuant to the split First and Second Admissions, Blake Hughes, Ross Andrews and Simon Pyper received a portion of their Placing Shares on First Admission. Their remaining investment has been included within the Second Admission along with Mark Ward as detailed below.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mark Ward
------------------------------- -----------------------------------
2. Reason for the Notification
--------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------- -----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- -----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- -----------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of EUR0.10 each ("Ordinary Shares")
the Financial
instrument, type
of instrument
Identification IDP GB00BT9PTW34
code
------------------------------- -----------------------------------
b) Nature of the Satisfaction of the obligation
transaction to repay GBP500,000 loan facility
provided by Mark Ward through
the issuance of 1,428,571
Placing Shares.
------------------------------- -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
35p 1,428,571
----------
------------------------------- -----------------------------------
d) Aggregated information: See 4c) above
Aggregated volume
Price
------------------------------- -----------------------------------
e) Date of the transaction 30 April 2021
------------------------------- -----------------------------------
f) Place of the transaction London Stock Exchange, Main
Market
------------------------------- -----------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Ross Andrews
------------------------------- ---------------------------------
2. Reason for the Notification
------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------- ---------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ---------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- ---------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- ---------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------
a) Description of EUR0.10 each ("Ordinary Shares")
the Financial
instrument, type
of instrument
Identification IDP GB00BT9PTW34
code
------------------------------- ---------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
------------------------------- ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
35p 164,549
----------
------------------------------- ---------------------------------
d) Aggregated information: See 4c) above
Aggregated volume
Price
------------------------------- ---------------------------------
e) Date of the transaction 30 April 2021
------------------------------- ---------------------------------
f) Place of the transaction London Stock Exchange, Main
Market
------------------------------- ---------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Blake Hughes
------------------------------- ---------------------------------
2. Reason for the Notification
------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------- ---------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ---------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- ---------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- ---------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------
a) Description of EUR0.10 each ("Ordinary Shares")
the Financial
instrument, type
of instrument
Identification IDP GB00BT9PTW34
code
------------------------------- ---------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
------------------------------- ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
35p 90,843
----------
------------------------------- ---------------------------------
d) Aggregated information: See 4c) above
Aggregated volume
Price
------------------------------- ---------------------------------
e) Date of the transaction 30 April 2021
------------------------------- ---------------------------------
f) Place of the transaction London Stock Exchange, Main
Market
------------------------------- ---------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Simon Pyper
------------------------------- ---------------------------------
2. Reason for the Notification
------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------- ---------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ---------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- ---------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- ---------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------
a) Description of EUR0.10 each ("Ordinary Shares")
the Financial
instrument, type
of instrument
Identification IDP GB00BT9PTW34
code
------------------------------- ---------------------------------
b) Nature of the Purchase of Ordinary Shares
transaction
------------------------------- ---------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
35p 50,468
----------
------------------------------- ---------------------------------
d) Aggregated information: See 4c) above
Aggregated volume
Price
------------------------------- ---------------------------------
e) Date of the transaction 30 April 2021
------------------------------- ---------------------------------
f) Place of the transaction London Stock Exchange, Main
Market
------------------------------- ---------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBBGDSDDDDGBC
(END) Dow Jones Newswires
April 29, 2021 07:24 ET (11:24 GMT)
1 Year Innovaderma Chart |
1 Month Innovaderma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
